A 24-Week, Multicenter, Randomized, Double-blind, Placebo-Controlled, Add-on, Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients with Parkinson#s Disease

Grants and Contracts Details

StatusFinished
Effective start/end date1/11/13 → 1/30/16

Funding

  • Inc Research Inc: $23,005.00